Waters Corporation (NYSE: WAT) is showcasing its portfolio of MassTrak™ solutions at the American Association of Clinical Chemistry annual meeting and Clinical Lab Expo July 25 - 29, 2010 in Anaheim in exhibit booth #4447. Waters portfolio of MassTrak Solutions for the clinical laboratory combines the power of separations science, tandem mass spectrometry, specialized chemistries, software, and support services in ways designed to optimize laboratory processes. Waters MassTrak Solutions shorten turnaround times and increase sensitivity, specificity and flexibility of assays for therapeutic drug monitoring, toxicology, and endocrinology when compared to traditional tests methods.
This year's AACC conference features more than 27 presentations on applications for LC/MS including a poster being presented by Waters scientists in collaboration with clinical scientists at Newcastle Hospital, United Kingdom on Tuesday, July 27. Applications for liquid chromatography and tandem mass spectrometry for the clinical laboratory are growing largely due to improvements in accuracy and precision, speed of analysis, and ease of use.
Waters-Sponsored Industry Workshop
On Tuesday, July 27 Waters is hosting a workshop on MassTrak LC/MS/MS Solutions for the clinical laboratory. The workshop provides customer based information on current LC/MS/MS best practices and will be helpful for those laboratorians considering implementing LC/MS/MS in their laboratory.
Featured presenters include:
- Gary Friedman, MD, Medical Director – Infectious Disease, Transplantation, and Immunology, Novartis
- Denise McKeown, Toxicology Research and Development, St. George's Hospital in London
- Les Perry, Ph.D., Principal Clinical Scientist, Dept. Of Clinical Biochemistry, Barts and the London NHS Trust.
New toolkit aims to help U.S. hospitals spot deadly viral hemorrhagic fevers faster and safer